BioCryst Pharmaceuticals, Inc. announced that the compensation committee of BioCryst’s board of directors granted 10 newly-hired employees inducement options to purchase an aggregate of 95,500 shares of BioCryst common stock on October 29, 2021 as inducements material to each employee entering into employment with BioCryst.
November 2, 2021
· 1 min read